Holding(s) in Company

AI SummaryClose X

Maven Capital Partners UK LLP, through Maven Renovar VCT PLC, has reduced its holding in Fusion Antibodies PLC, with its voting rights falling from 3.86% to 2.76% as of November 21, 2025. This change represents a decrease of 1,250,000 voting rights, bringing the total number of voting rights held to 3,136,463. The notification was made on November 25, 2025.

Disclaimer*

UK 100

Latest directors dealings